CFM
OM icon

Catalyst Funds Management’s Outset Medical OM Stock Holding History

Catalyst Funds Management’s Portfolio OM Stock Details OM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$82.9K Buy
+19,201
New +$84K ﹤0.01% 624
2024
Q4 		– Sell
-840
Closed -$8.53K – 970
2024
Q3 		$8.53K Hold
840
– – ﹤0.01% 1206
2024
Q2 		$48.5K Buy
+840
New +$41.2K 0.01% 435

Other funds holding OM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Catalyst Funds Management's OM Position: Q2 2026 in Review

Catalyst Funds Management opened a new position in Outset Medical (OM) in Q2 2026: 19,201 shares worth $82.9K. The stake represents ﹤0.01% of the portfolio and ranks #624 among its holdings. This is a return to the name: Catalyst Funds Management previously reported a position in OM as recently as Q3 2024.

Catalyst Funds Management first reported a position in OM in Q2 2024 and has held it in 3 quarters since. 93 funds tracked by Wall St. Rank hold OM as of Q2 2026.

  • Catalyst Funds Management held 19,201 shares of Outset Medical worth $82.9K as of Q2 2026.
  • Outset Medical was a new Catalyst Funds Management position in Q2 2026.
  • Outset Medical made up ﹤0.01% of Catalyst Funds Management's portfolio in Q2 2026, its #624 holding.
  • Catalyst Funds Management first reported a position in Outset Medical in Q2 2024 and has held it in 3 quarters since.
  • 93 funds tracked by Wall St. Rank held Outset Medical as of Q2 2026.

Based on Catalyst Funds Management's 13F filing for Q2 2026, filed 10 Aug 2026.